Vericel Corporation

Last updated September 27, 2026

Organization details

Legal name
Vericel Corporation
Former names
Aastrom Biosciences Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Michigan
Headquarters city
Burlington
Headquarters state / province
Massachusetts
Headquarters country
United States
Fiscal year end
December
Ticker symbol
VCEL
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000887359
EIN
94-3096597

Board of directors

Chief executives

Dominick Colangelo · President and CEO
Dates unknown

Director election results

Annual meeting of April 29, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of Vericel Corporation's board connections Akebia Therapeutics Inc. Akebia Therapeutics In... Invivyd Inc. Invivyd Inc. Obsidian Therapeutics Inc. Obsidian Therapeutics... SCYNEXIS Inc. SCYNEXIS Inc. Trevi Therapeutics Inc. Trevi Therapeutics Inc... Dominick Colangelo Dominick Colangelo Heidi Hagen Heidi Hagen Kevin F. Mclaughlin Kevin F. Mclaughlin Steven C. Gilman Steven C. Gilman Vericel Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$11,016,486
40 sales by 9 insiders
Date Insider Transaction Shares Price Value
Nov 6, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Option exercise +14,068 $34.90 $490,973
Nov 6, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Open-market sale −14,068 $53.41 $751,372
Nov 6, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Option exercise +14,573 $29.82 $434,567
Nov 6, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Open-market sale −14,573 $53.43 $778,635
Nov 5, 2026 Flynn Sean C. Officer (Chief Legal Officer) Option exercise +15,000 $16.25 $243,750
Nov 5, 2026 SIEGAL JONATHAN Officer (Principal Accounting Officer) Option exercise +1,500 $34.90 $52,350
Nov 5, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Option exercise +10,932 $34.90 $381,527
Nov 5, 2026 Flynn Sean C. Officer (Chief Legal Officer) Open-market sale −15,000 $51.92 $778,800
Nov 5, 2026 SIEGAL JONATHAN Officer (Principal Accounting Officer) Open-market sale −1,500 $52.90 $79,350
Nov 5, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Open-market sale −10,932 $53.40 $583,769
Nov 5, 2026 Robert L. Zerbe M.D. Director Option exercise +500 $13.05 $6,525
Nov 5, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Option exercise +10,427 $29.82 $310,933
Nov 5, 2026 Robert L. Zerbe M.D. Director Open-market sale −500 $55.00 $27,500
Nov 5, 2026 Mara Joseph Anthony Jr Officer (Chief Financial Officer) Open-market sale −10,427 $53.73 $560,243
Nov 5, 2026 Robert L. Zerbe M.D. Director Option exercise +2,500 $13.05 $32,625

Organizations in the same sector, closest in location and size first.

Questions about Vericel Corporation

Who is the CEO of Vericel Corporation?

Dominick Colangelo is Vericel Corporation's President and CEO.

How many directors are on Vericel Corporation's board?

Vericel Corporation's board has 8 directors: Alan L. Rubino, Dominick Colangelo, Heidi Hagen, Kevin F. Mclaughlin, Lisa Wright, Paul K. Wotton, Robert L. Zerbe M.D. and Steven C. Gilman.

Are Vericel Corporation insiders buying or selling shares?

Over the last 12 months, Vericel Corporation insiders made no open-market purchases and sold $11.0 million of shares in 40 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="vericel-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.